Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
29,579,261
-
Total 13F shares
-
3,162,453
-
Share change
-
-42,249
-
Total reported value
-
$64,565,945
-
Price per share
-
$20.42
-
Number of holders
-
53
-
Value change
-
-$620,909
-
Number of buys
-
33
-
Number of sells
-
23
Institutional Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q3 2018
As of 30 Sep 2018 abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) had 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,162,453 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, NEEDHAM INVESTMENT MANAGEMENT LLC, RAYMOND JAMES & ASSOCIATES, FLAGSHIP HARBOR ADVISORS, LLC, WELLS FARGO & COMPANY/MN, Invesco Ltd., COHEN & STEERS INC, Claraphi Advisory Network, LLC, LPL Financial LLC, and Advisor Group, Inc..
This table shows 53 institutional shareholders of the security as of 30 Sep 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.